DCF — SANTA CLARA VALLEY MEDICAL CENTER
Enterprise Value: $-2.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.3B
Enterprise Value
$-754.9M
PV of Cash Flows
$-1.5B
PV of Terminal Value
$-2.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.6B | $-118.3M | -5.0% | $-229.5M | $-208.7M |
| Year 2 | $2.7B | $-94.7M | -4.0% | $-209.3M | $-173.0M |
| Year 3 | $2.8B | $-69.7M | -3.0% | $-187.7M | $-141.0M |
| Year 4 | $2.9B | $-57.4M | -2.0% | $-179.0M | $-122.3M |
| Year 5 | $3.0B | $-51.8M | -2.0% | $-177.0M | $-109.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.6B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000001959505
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5